Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer

Mark W Burns, Eric S Kim Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Abstract: Lung cancer has become one of the leading causes of death in both men and women in the United States, with approximately 230,000 new cases and 160,000 deaths each year. Approximately 80% of lung can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Burns MW, Kim ES
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/615bc03c1c684229b384790e7c3150d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!